ATA180191A - Furanderivate enthaltende pharmazeutische präparate - Google Patents

Furanderivate enthaltende pharmazeutische präparate

Info

Publication number
ATA180191A
ATA180191A AT0180191A AT180191A ATA180191A AT A180191 A ATA180191 A AT A180191A AT 0180191 A AT0180191 A AT 0180191A AT 180191 A AT180191 A AT 180191A AT A180191 A ATA180191 A AT A180191A
Authority
AT
Austria
Prior art keywords
furanderivates
pharmaceutical preparations
preparations containing
salt
bismuth
Prior art date
Application number
AT0180191A
Other languages
English (en)
Other versions
AT405134B (de
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ATA180191A publication Critical patent/ATA180191A/de
Application granted granted Critical
Publication of AT405134B publication Critical patent/AT405134B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Saccharide Compounds (AREA)
AT0180191A 1990-09-11 1991-09-10 Furanderivate enthaltende pharmazeutische präparate AT405134B (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB909019875A GB9019875D0 (en) 1990-09-11 1990-09-11 Pharmaceutical compositions
NO920408A NO179694C (no) 1990-09-11 1992-01-30 Farmasöytiske preparater inneholdende ranitidinderivater
PCT/EP1992/000498 WO1993017679A1 (en) 1990-09-11 1992-03-05 Compositions containing ranitidine/bismuth carboxylates salts

Publications (2)

Publication Number Publication Date
ATA180191A true ATA180191A (de) 1998-10-15
AT405134B AT405134B (de) 1999-05-25

Family

ID=47884627

Family Applications (2)

Application Number Title Priority Date Filing Date
AT0180191A AT405134B (de) 1990-09-11 1991-09-10 Furanderivate enthaltende pharmazeutische präparate
AT92103741T ATE122883T1 (de) 1990-09-11 1992-03-05 Arzneimittel enthaltend ranitidin/wismutcarboxylat-salze.

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT92103741T ATE122883T1 (de) 1990-09-11 1992-03-05 Arzneimittel enthaltend ranitidin/wismutcarboxylat-salze.

Country Status (33)

Country Link
US (1) US5456925A (de)
EP (1) EP0558779B1 (de)
JP (1) JPH0692849A (de)
KR (1) KR100196308B1 (de)
AT (2) AT405134B (de)
AU (2) AU640816B2 (de)
BE (1) BE1005115A5 (de)
BG (1) BG61931B1 (de)
CA (1) CA2050970C (de)
CH (1) CH683068A5 (de)
CY (1) CY1988A (de)
DE (2) DE4130061A1 (de)
DK (1) DK159191A (de)
ES (1) ES2072647T3 (de)
FI (1) FI944047A0 (de)
FR (1) FR2666508B1 (de)
GB (2) GB9019875D0 (de)
HK (1) HK60894A (de)
HU (1) HU211846A9 (de)
IE (1) IE65049B1 (de)
IL (1) IL99428A (de)
IT (1) IT1249696B (de)
MX (1) MX9101009A (de)
NL (1) NL194907C (de)
NO (1) NO179694C (de)
NZ (1) NZ239731A (de)
OA (1) OA10093A (de)
RO (1) RO112084B1 (de)
RU (1) RU2108097C1 (de)
SE (1) SE509694C2 (de)
SK (1) SK279591B6 (de)
WO (1) WO1993017679A1 (de)
ZA (1) ZA917176B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions
GB9120131D0 (en) * 1991-09-20 1991-11-06 Glaxo Group Ltd Medicaments
DK0550083T3 (da) * 1991-12-06 1999-10-11 Glaxo Group Ltd Lægemidler til behandling af inflammatoriske tilstande eller til analgesi og indeholdende et NSAID og ranitidinbismuthcitra
GB9127150D0 (en) * 1991-12-20 1992-02-19 Smithkline Beecham Plc Novel treatment
GB9501560D0 (en) 1995-01-26 1995-03-15 Nycomed Imaging As Contrast agents
JPH10512877A (ja) * 1995-01-26 1998-12-08 ニコムド イメージング エイ／エス ビスマス化合物
RU2203048C2 (ru) * 1998-08-18 2003-04-27 Леонидов Николай Борисович Физически устойчивая рентгеноаморфная форма ранитидина гидрохлорида с повышенной противоязвенной активностью и способ ее получения
EP1104673A1 (de) * 1999-11-30 2001-06-06 Bayer Classics Ein Hydrogencarbonat enthaltendes sprengmittelfreies Arzneimittel
KR100412290B1 (ko) * 2001-11-27 2003-12-31 주식회사 동구제약 라니티딘 함유 현탁제 조성물 및 그의 제조방법
US20060100271A1 (en) * 2004-11-08 2006-05-11 Keith Whitehead Stabilized aqueous ranitidine compositions
US9629809B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
MX337488B (es) * 2008-07-21 2016-03-08 Si Group Inc Granulos con alto contenido de ibuprofeno sodico, su preparacion y su uso en preparar formas de dosificacion solidas no efervescentes.
US20230218663A1 (en) * 2020-06-01 2023-07-13 The University Of Hong Kong Compositions and methods for treating a sars-cov-2 infection

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4608257A (en) * 1984-01-03 1986-08-26 Board Of Regents For Oklahoma State University Composition and method for treating heat stress
GB8629781D0 (en) * 1986-12-12 1987-01-21 Glaxo Group Ltd Pharmaceutical compositions
EP0282132B1 (de) * 1987-03-09 1992-09-30 The Procter & Gamble Company Zusammensetzungen und ihre Verwendung zur Behandlung von Magen-Darmstörungen
DE3710462A1 (de) * 1987-03-30 1988-10-13 Heumann Pharma Gmbh & Co Pharmazeutische zubereitung zur behandlung von erkrankungen des magen-darm-traktes
FR2633181B1 (fr) * 1988-06-24 1992-01-10 Glaxo Lab Sa Composition pharmaceutique a base de ranitidine et son procede de preparation
CH679582A5 (de) * 1988-07-18 1992-03-13 Glaxo Group Ltd
EP0363502B1 (de) * 1988-10-08 1991-09-25 Dr. R. Pfleger Chemische Fabrik Gmbh Flüssiges, wismuthaltiges Arzneipräparat, Verfahren zum Herstellen desselben und seine Verwendung
AU641903B2 (en) * 1988-10-26 1993-10-07 Glaxo Group Limited Carboxylic acid derivatives
US5013560A (en) * 1989-03-17 1991-05-07 The Procter & Gamble Company Microbially-stable bismuth-containing liquid pharmaceutical suspensions
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions

Also Published As

Publication number Publication date
EP0558779A1 (de) 1993-09-08
FR2666508B1 (fr) 1994-02-18
IE65049B1 (en) 1995-10-04
IL99428A0 (en) 1992-08-18
GB9019875D0 (en) 1990-10-24
KR920005984A (ko) 1992-04-27
NZ239731A (en) 1993-10-26
NO920408D0 (no) 1992-01-30
FR2666508A1 (fr) 1992-03-13
ATE122883T1 (de) 1995-06-15
BE1005115A5 (fr) 1993-04-27
BG99021A (bg) 1995-06-30
DK159191D0 (da) 1991-09-10
CY1988A (en) 1997-09-05
SE9102604D0 (sv) 1991-09-10
BG61931B1 (bg) 1998-10-30
IL99428A (en) 1996-06-18
GB2248185A (en) 1992-04-01
SK106094A3 (en) 1995-02-08
ES2072647T3 (es) 1995-07-16
US5456925A (en) 1995-10-10
CA2050970C (en) 2002-11-19
ZA917176B (en) 1992-06-24
RU2108097C1 (ru) 1998-04-10
AT405134B (de) 1999-05-25
AU640816B2 (en) 1993-09-02
CH683068A5 (fr) 1994-01-14
RO112084B1 (ro) 1997-05-30
SK279591B6 (sk) 1999-01-11
FI944047L (fi) 1994-09-02
NL9101533A (nl) 1992-04-01
NO179694B (no) 1996-08-26
ITRM910673A1 (it) 1993-03-10
GB9119284D0 (en) 1991-10-23
AU8375791A (en) 1992-03-19
FI944047A7 (fi) 1994-09-02
DK159191A (da) 1992-03-12
JPH0692849A (ja) 1994-04-05
NL194907B (nl) 2003-03-03
SE9102604L (sv) 1992-03-12
NO179694C (no) 1996-12-04
HU211846A9 (en) 1995-12-28
SE509694C2 (sv) 1999-02-22
DE4130061A1 (de) 1992-03-12
HK60894A (en) 1994-07-08
KR100196308B1 (ko) 1999-06-15
IT1249696B (it) 1995-03-09
EP0558779B1 (de) 1995-05-24
GB2248185B (en) 1994-02-02
ITRM910673A0 (it) 1991-09-10
AU1334792A (en) 1993-10-05
IE913191A1 (en) 1992-04-22
FI944047A0 (fi) 1994-09-02
MX9101009A (es) 1992-05-04
WO1993017679A1 (en) 1993-09-16
CA2050970A1 (en) 1992-03-12
NL194907C (nl) 2003-07-04
NO920408L (no) 1993-08-02
DE69202696D1 (de) 1995-06-29
OA10093A (en) 1996-12-18

Similar Documents

Publication Publication Date Title
DK0609210T3 (da) Optisk aktivt 5H-pyrrolo(3,4-b)pyrazinderivat, dets fremstilling og farmaceutiske præparater deraf
DK159191D0 (da) Farmaceutiske praeparater
DE69013473D1 (de) Cimetidin enthaltende Arzneimittel.
ES2058651T3 (es) Uso derivados de guanidina para la fabricacion de un medicamento con actividad antagonista de npy.
ATA154489A (de) Feste pharmazeutische ranitidinpraeparate
DK585886A (da) Immunstimulerende middel og anvendelse deraf
TR24895A (tr) PIRIMIDIN TüREVLERI,BUNLARIN ISTIHSAL EDILMESI VE KULLANILMASI
DK403789A (da) Et nyt antibiotikum, mersacidin, dets fremstilling og anvendelse som laegemiddel
FI864164A7 (fi) Ihmis- -interferonin biologisesti aktiivisia johdoksia, niiden valmistus ja tällaisia johdoksia sisältävlääkkeitä.
DE68902300D1 (de) Pharmazeutische loesung enthaltend salbutamol und cromoglycinsaeure.
DK0437225T3 (da) Topiske præparater
DK159780C (da) (-)-1beta-ethyl-1alfa-hydroxylmethyl-1,2,3,4,6,7,12,12balfa-octahydroindolo(2,3-a)quinolizin og syreadditionssalte deraf, dens fremstilling og farmaceutisk praeparat indeholdende den
DE3876425D1 (de) Gesteuerte verabreichung eines heilmittels an blut.
DE3865642D1 (de) Pharmazeutische zubereitung zur cholelitholyse.
NO873385D0 (no) Oksiran-pseudooligosakkarider, fremgangsmaate til deres fremstilling, deres anvendelse og farmasoeytiske preparater.
FR2191842A2 (en) Insecticidal compsns contg thiapyrans - 4-(4'-methyl-3'-hexenyl) 5,6-dihydro-2-H-thiapyran and its 5-oxide have juvenile hormone activity
IT8723046A0 (it) Agente nootropo, sua preparazione e impiego.
ATE78684T1 (de) Pharmazeutische loesung enthaltend salbutamol und cromoglycinsaeure.
ATE24275T1 (de) Pharmazeutische zubereitungen mit zytostatischer wirkung.
GB2162746A (en) Antiacidotic medicinal agent
ATE64535T1 (de) Xylometazolinhaltige pharmazeutische praeparate.

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee